Contrast Ultrasound Imaging for Identification of Early Responder Tumor Models to Anti-Angiogenic Therapy

Agents targeting vascular endothelial growth factor (VEGF) have been validated as cancer therapeutics, yet efficacy can differ widely between tumor types and individual patients. In addition, such agents are costly and can have significant toxicities. Rapid noninvasive determination of response coul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sirsi, Shashank, Flexman, Molly, Vlachos, Fotis, Huang, Jianzhong, Hernandez, Sonia L., Kim, Hyun Keol, Johung, Tessa J., Gander, Jeffrey, Reichstein, Ari, Lampl, Brooke S., Wang, Antai, Hielscher, Andreas H., Kandel, Jessica J., Yamashiro, Darrell J., Borden, Mark
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2012
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3348332/
https://ncbi.nlm.nih.gov/pubmed/22425376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ultrasmedbio.2012.01.014
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge